NEW YORK (GenomeWeb News) – Opko Health has received a $1 million grant from the Bill and Melinda Gates Foundation for the development of a tuberculosis test, the company announced today.

The grant will support development of a test for distinguishing latent TB from active TB using Opko's molecular diagnostics technology. The Miami-based firm also leverages the technology to create blood-based tests for identifying biomarkers for diseases including neurodegenerative disorders and malignancies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.